MENU
+Compare
GLYC
Stock ticker: NASDAQ
AS OF
Apr 16, 04:59 PM (EDT)
Price
$0.22
Change
-$0.01 (-4.35%)
Capitalization
14.7M

GLYC GlycoMimetics Forecast, Technical & Fundamental Analysis

GlycoMimetics Inc is a clinical-stage biotechnology company... Show more

Industry: #Biotechnology
GLYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for GLYC with price predictions
Apr 15, 2025

GLYC in upward trend: price expected to rise as it breaks its lower Bollinger Band on March 28, 2025

GLYC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 43 cases where GLYC's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where GLYC's RSI Oscillator exited the oversold zone, of 37 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on April 14, 2025. You may want to consider a long position or call options on GLYC as a result. In of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for GLYC just turned positive on April 14, 2025. Looking at past instances where GLYC's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where GLYC advanced for three days, in of 240 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

GLYC moved below its 50-day moving average on March 21, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GLYC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for GLYC entered a downward trend on April 03, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. GLYC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.765) is normal, around the industry mean (13.431). P/E Ratio (0.000) is within average values for comparable stocks, (63.021). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.766). Dividend Yield (0.000) settles around the average of (0.026) among similar stocks. GLYC's P/S Ratio (2000.000) is slightly higher than the industry average of (250.615).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GLYC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
GLYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

GLYC is expected to report earnings to rise 37.50% to -10 cents per share on November 29

GlycoMimetics GLYC Stock Earnings Reports
Q3'24
Est.
$-0.11
Q4'24
Beat
by $0.01
Q2'24
Est.
$-0.16
Q1'24
Missed
by $0.01
Q4'23
Beat
by $0.01
The last earnings report on February 27 showed earnings per share of -7 cents, beating the estimate of -9 cents. With 46.58K shares outstanding, the current market capitalization sits at 14.70M.
A.I. Advisor
published General Information

General Information

a developer of drugs to treat inflammatory diseases and cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
9708 Medical Center Drive
Phone
+1 240 243-1201
Employees
35
Web
https://www.glycomimetics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA254.111.76
+0.70%
Tesla
AAPL202.14-0.38
-0.19%
Apple
SPY537.61-1.51
-0.28%
SPDR® S&P 500® ETF
BTC.X83668.990000-873.398440
-1.03%
Bitcoin cryptocurrency
GME26.70-0.28
-1.04%
GameStop Corp

GLYC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GLYC has been closely correlated with LYRA. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if GLYC jumps, then LYRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLYC
1D Price
Change %
GLYC100%
+2.61%
LYRA - GLYC
76%
Closely correlated
-13.26%
ROQAF - GLYC
72%
Closely correlated
N/A
EYPT - GLYC
46%
Loosely correlated
-0.70%
IONS - GLYC
35%
Loosely correlated
-1.05%
ALLO - GLYC
33%
Loosely correlated
+2.10%
More

Groups containing GLYC

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLYC
1D Price
Change %
GLYC100%
+2.61%
GLYC
(2 stocks)
94%
Closely correlated
-1.83%